On 19 January 2017
Hester Biosciences announced that a Meeting of the Board of Directors of the Company will be held on 19 January 2017, to consider the Unaudited Standalone Financial Results for the quarter ended on 31 December 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
